Monday Jul 7
The Motley Fool
Why Hologic Inc. Shares Could Stall
While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense.
Hologic Rating Lowered to Hold at Standpoint Research
Hologic traded down 0.81% on Wednesday, hitting $25.59. 2,627,491 shares of the company's stock traded hands.
Hologic Receives Average Rating of "Hold" from Analysts
Shares of Hologic have been given a consensus rating of "Hold" by the twenty-one analysts that are covering the company, American Banking News reports .
Hologic PT Raised to $30.00
Needham & Company LLC's price target points to a potential upside of 19.33% from the company's current price.
3-D Mammogram Makes Better Breast Cancer Test, Study Says
Hologic Inc. 's three-dimensional mammograms, when paired with traditional screening, caught more deadly breast cancers than standard scans alone and resulted in fewer women being called back for more testing, a study found.